Abstract
1082 Background: Patients (pts) with triple negative breast cancer (TNBC) with residual disease after neoadjuvant therapy have a high risk of recurrence. Methods: Pts with BRCA mutations and/or TNB...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
